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This monograph forms part of a series of disease monographs commissioned by the 
International Development Research Centre over the period Nov 2015 to April 2016 to 
inform funding priorities for the Livestock Vaccine Innovation Fund (LVIF). The LVIF is a 
seven-and-a-half year, CA$57 million partnership between the Bill & Melinda Gates 
Foundation, Global Affairs Canada and Canada’s International Development Research 
Centre. It focuses on those animal diseases posing the greatest risk to poor livestock 
keepers in Sub-Saharan Africa, South and Southeast Asia, targeting transboundary 
diseases to achieve lasting regional impact. 
 
The content presented here is as submitted by the consultant(s) involved and has been 
edited for appearance only. The views, information, or opinions expressed in this 
monograph are solely those of the individual consultant(s) involved and do not 
necessarily represent those of the Bill & Melinda Gates Foundation, Global Affairs Canada 
and International Development Research Centre, or any of their employees. Sections of 
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Etiology and relevance 
Heartwater or cowdriosis is specific to cattle, sheep, goats and some wild ruminants, and is prevalent in much of 
Africa and the Caribbean. It results from infection by Ehrlichia (formerly Cowdria) ruminantium, a small, Gram 
negative, pleomorphic coccus in the family Anaplasmataceae and order Rickettsiales. This organism is an 
obligate intracellular parasite. Strains of E. ruminantium are very diverse; while some strains are highly virulent, 
others appear to be non-pathogenic. E. ruminantium has a high level of genomic plasticity. Gene segments are 
often deleted or inserted, and genes may be disrupted. Several different genotypes can co-exist in a geographic 
area, and may recombine to form new strains 
E. ruminantium is transmitted by ticks of the genus Amblyomma.  
Heartwater is most severe in small ruminants, but also causes heavy losses in exotic cattle, which are more 
susceptible than indigenous breeds. However, indigenous cattle can also be affected if poor conditions weaken 
their immune system, or if animals are moved from an area free of heartwater to an area in which it is endemic. 
Heartwater is difficult to diagnose and only Giemsa-stained smears of crushed cerebral grey matter can confirm 
the presence of colonies of the organism in the endothelial cells of the capillaries. Small ruminants affected by 
Cowdria present distinctive nervous symptoms: in peracute forms, animals generally drop suddenly to the 
ground, start ‘pedalling’ with their legs and rapidly die. These nervous symptoms are very common in the later 
stages of the disease, but can be confused with signs of poisoning or other diseases such as tetanus or rabies. 
Postmortems are rarely performed and accurate information on the incidence of heartwater is generally lacking. 
Furthermore, serological tests are generally not satisfactory due to cross reactions with other organisms such as 
Ehrlichia. 
In tropical and subtropical areas, the disease is endemic and results in considerable economic losses due to loss 
of production, treatment costs and reduced initiatives for the upgrading of local breeds of livestock with more 
susceptible exotic breeds. Heartwater is considered by some groups as the second most economically important 
tick borne disease of livestock in Africa, after ECF. Furthermore, it affects not only cattle, but essentially small 
ruminants, considered to be of great importance to poor livestock keepers. Prevalence information is not always 
available and in some studies is shown to be low. This is attributed to endemic stability in affected areas. The 
endemic situation however restricts the introduction of improved naïve breed or animals in these affected 
regions. 
Control and immunisation 
Heartwater has traditionally been controlled by the use of chemical acaricides to prevent or reduce transmission 
by Amblyomma spp. Oxytetracycline treatment is normally successful if administered early, and is also used in a 
prophylactic manner on very valuable and susceptible animals during the peak Amblyomma season. This 
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method, although not recommended by veterinarians, is widely used by commercial farmers in South Africa and 
by local farmers when they have to move their cattle through an endemic area. The protection conferred by the 
antibiotic is effective not only against infection with heartwater, but also against other tick-borne diseases, and 
animals may develop their own immunity if naturally challenged during this coverage. 
A blood-based vaccine containing live Cowdria organisms is used in South Africa. It is an “infection and 
treatment” type of immunization using live organisms generated from blood of live sheep used for vaccination 
of animals that are subsequently treated with antibiotics at specific time during the course of infection. This 
blood vaccine is the only registered vaccine in the South Africa and nothing in any other countries. The presence 
of wide diversity in stocks of E ruminantium genotypes circulating in animals and ticks in different geographical 
regions resulting in different immunogenic types hamper vaccine development and limit the wide use of the 
current commercial blood vaccine. It does not protect against all of the isolates and, therefore, not used beyond 
South Africa, and even within South Africa, not throughout the disease endemic areas. Furthermore the vaccine 
requires a strict cold chain and can cause severe clinical reactions. 
Over the years, research has focused on inactivated vaccine, with two groups having worked extensively on the 
development work: the University of Florida and CIRAD. These two institutions have inactivated different stocks 
of the E. ruminantium organism, as single or as combination of stocks. Despite good results obtained on small 
scale and generally homologous challenge studies, these early successes were unfortunately not repeated when 
trials were conducted in heterologous challenge studies or in field situations, where natural tick challenge with 
genotypes having differing immunogenicities would have occurred. Several reports indicate that under these 
circumstances the vaccine reduces mortality levels, but protection levels have been disappointing. The different 
studies conducted by the University of Florida group for example show that overall mortality levels of 71% in 
naive animals can be reduced to 36% by vaccination. 
A number of positive outcomes have however been achieved which could contribute to the development of 
better vaccine for Heartwater. These include the development of efficient and cost effective cell culturing 
system, better inactivation processes and identification of suitable adjuvants. The CIRAD group has been able to 
demonstrate a drop in the production cost of a potential inactivated Heartwater vaccine to around US$0.14 per 
dose.   
Having successfully managed to attenuate the cross-protective Welgevonden stock and developed a cell culture 
system, the OVI has developed an attenuated vaccine that is currently undergoing field evaluation in South 
Africa.  
Recombinant technology has been used to develop DNA vaccines formulations which have been tried in mice 
and sheep: most of the work has been based on the immunisation with DNA vaccine containing the map1 gene 
of E. ruminantium. None of the different attempts or forms has been taken beyond proof of concept 
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The future if Heartwater vaccines and vaccination 
Given the importance of the disease, and also the fact that it affects most poor livestock keepers in Sub-Saharan 
Africa who keep small ruminants, and also given the challenges associated with chemotherapy and vector 
control through the use of acaricides, immunisation remains the best options for the control of this important 
disease. A number of actions could be considered in order to contribute toward the development of effective 
immunisation approaches: 
• There is a need to validate molecular tools for rapid field strain matching to possible vaccines   
• Evaluate inactivated form of vaccines based on broad spectrum isolates or stock, such as Welgevonden, 
using knowledge accumulated by the different groups  
• Evaluate vaccines based on mixed stocks, live attenuated or inactivated 
• Evaluate combination vaccination program, with priming with inactivated vaccine and boosting with live 
attenuated vaccine 
• Conduct a full development on the attenuated Welgevonden vaccine, essentially assess reversion to 
virulence and possibly lyophilisation 
• Development of robust challenge models, which should preferably include a tick challenge  
• Conduct a detailed assessment of recombinant candidate vaccines, and include vaccine development 
knowledge to the groups currently developing these approaches, which generally are made of scientists with 
no vaccine development expertise  
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The first reference to what may have been heartwater was made in South Africa by the Voortrekker pioneer 
Louis Trichardt in 1838 [32]. It is only in 1900 that Lounsbury published his confirmation of the long-standing 
suspicion that the bont tick (Amblyomma hebraeum) was the vector of heartwater in South Africa, but another 
quarter of a century elapsed before Cowdry demonstrated that the infectious agent in the tissues of infected 
animals and ticks was a rickettsia which he named Rickettsia ruminantium. The name was later changed to 
Cowdria ruminantium and eventually to Ehrlichia ruminantium [3] 
Heartwater results from infection by Ehrlichia  ruminantium, a small, Gram negative, pleomorphic coccus in the 
family Anaplasmataceae and order Rickettsiales (Figure 1). This organism is an obligate intracellular parasite. 
Strains of E. ruminantium are very diverse; while some strains are highly virulent, others appear to be non-
pathogenic. E. ruminantium has a high level of genomic plasticity. Gene segments are often deleted or inserted, 
and genes may be disrupted. Several different genotypes can co-exist in a geographic area, and may recombine 
to form new strains. 
E. ruminantium was traditionally classified as the sole species of the genus Cowdria, tribe Ehrlichieae, family 
Rickettsiaceae, order Rickettsiales [33]. It had long been realized, however, that the organism had a close 
antigenic relationship with certain Ehrlichia spp., and in 1992 the first molecular phylogeny of the organism, 
based on the 16S ribosomal RNA gene sequence of the Zimbabwean Crystal Springs isolate, revealed that it was 
related to Anaplasma marginale. This was closely followed by an analysis of the (slightly different) 16S sequence 
of the Senegal isolate, which showed a closer relationship to Ehrlichia canis and Ehrlichia chaffeensis than to E. 
ruminantium [11]. 
As the 16S genes of more organisms of the family Rickettsiaceae were sequenced it became evident that the 
genus Ehrlichia did not constitute a monophyletic group, and that organisms classified as Anaplasma, Cowdria, 
and Neorickettsia were members of three separate clades, each of which included various organisms classified 
as Ehrlichia spp. [22]. These clades became known as genogroups I, II and III Ehrlichia (Figure 2) with C. 
ruminantium being included in genogroup III, together with E. canis, E. chaffeensis, E. muris and E. ewingi. [3]. See 
Figure 2.  
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Figure 2: Maximum likelihood tree based on 16S ribosomal RNA gene sequences in the order Rickettsiales 
before reclassification, with Escherichia coli as outgroup. Note species classified as Ehrlichia occurring in 
three separate paraphyletic clades (genogroups). Cowdria ruminantium is located in genogroup III [3] 
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Genetic diversity and poor cross protective ability among genotypes or stocks 
As the 16S genes of more isolates of Cowdria became available it was found that E. ruminantium was not a 
relatively homogeneous entity and that there were several distinct Cowdria 16S genotypes, all of which fell into 
a tight cluster within the genogroup III Ehrlichia. It is now known that there is far more genetic variability among 
E. ruminantium organisms than had ever been suspected [11][22]. 
Based on existing stocks of E. ruminantium, 8 different 16S ribosomal RNA genotypes are known, all classified at 
present as E. ruminantium. However, 16S sequence data cannot be used as the sole determinant of what 
constitutes a species; it is also important to be able to grow a stock in tissue culture in order to accurately 
determine its disease-causing status, and this has not been done for several of these eight genotypes. Some of 
them are undoubtedly justifiably classified as E. ruminantium, but others may need to be reclassified in the 
future in the light of their infectivity and pathogenicity in ruminant hosts [3]. See Table 1.  
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With the now well recognised existence of immunogenic variants, it is obviously of crucial importance for the 
development of vaccines to have an understanding of which stocks can confer complete or partial cross-immunity 
one to another in ruminants. Poor cross-protection between stocks or even none at all, has been shown in several 
experiments but several of these experiments included at least one stock now known to be genetically 
heterogeneous. Table 2 below provides the result of an experiment carried out at Onderstepoort with six different 
E. ruminantium stocks in sheep [3]. Full cross-protection was essentially seen only with the Welgevonden stock.  





Table 3: Variability among E. ruminantium stocks as shown in Infectivity studies: three different types of 
pathogenicity are evidenced [5]  
 
 
+=pathogenic; +/-=mildly pathogenic; -= non-pathogenic; ()= non-infective; ND= not done 
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Susceptible animal species  
 
Domestic ruminants, notably cattle, sheep and goats are most susceptible to heartwater. Heartwater is most 
severe in small ruminants, but also causes heavy losses in exotic cattle, which are more susceptible than 
indigenous breeds. As shown in Table 4 below, a large number and variety of wild African and non-African 
ruminants are susceptible to infection with heartwater giving rise to the suspicion that some, in heartwater-
endemic areas, may serve as reservoirs of the disease [21]. This suspicion was confirmed with the finding that the 
African buffalo (Syncerus caffer), which are excellent natural hosts for the vectors are, after recovery from 
heartwater, chronically infected and intermittently infective for ticks for many months. 
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Vectors of Bovine anaplasmosis and transmission 
Heartwater is transmitted by ticks from the genus Amblyomma. Ticks become infected as larvae or nymphs, and 
can transmit the disease as nymphs or adults. Transovarial passage is not significant in the epidemiology of 
heartwater, and may not occur. Cattle importations have been implicated in the dispersal of Amblyomma ticks 
into the Caribbean. At least twelve species of Amblyomma can transmit E. ruminantium. A. variegatum (the 
tropical bont tick) is the major vector in Africa and the Caribbean (Figure 3). Subsequently the distribution of the 
disease in Africa coincides with that of the two most important vector species, A. variegatum and A. hebraeum, 
the later, the bont tick, especially in southern Africa [31]. Other known vectors include A. lepidum (in East Africa 
and the Sudan), A. astrion, and A. pomposum. A. sparsum, A. gemma, A. cohaerans, A. marmoreum and A. 
tholloni (the elephant tick) are capable of transmitting experimental infections [31]. Two North American species, 
A. maculatum (the Gulf Coast tick) and A. cajennense, can transmit E. ruminantium in the laboratory, but neither 
has been implicated in natural infections. E. ruminantium gene segments have been found, by PCR, in the ticks 
Rhipicephalus evertsi, Hyalomma truncatum and Hyalomma marginatum; however, the organism was never 
isolated [24]. 
Ticks become infected by feeding on acutely ill or sub-clinically infected animals. Experimentally infected carrier 
sheep can infect ticks for at least seven months. Cattle can infect ticks for a minimum of eight months. Blesbok, 
black wildebeest, blue wildebeest, African buffalo, eland, giraffe, greater kudu and sable antelope can also 
become carriers [32]. Infections have been detected for up to six months in some wild ruminants. E. ruminantium 
is very fragile and does not survive outside a host for more than a few hours at room temperature.  




Figure 3:  Amblyomma variegatum (Tropical bont tick). [3] 
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Heartwater is endemic in most of Africa south of the Sahara desert (Figure 4), as well as in surrounding islands 
such as Madagascar, and in the Caribbean. 
The distribution of the disease in Africa coincides with that of the two most important vector species, A. 
variegatum and A. hebraeum [7]. The vector occurs in Africa, south of the Sahel area, from Senegal to Ethiopia 
and to the extreme north-west of Somalia. It is prevalent in central and eastern Africa, and also in part of 
Botswana, Zimbabwe and Mozambique. In eastern Angola, southern Democratic Republic of Congo (DRC) and in 
Zambia, it overlaps with A. pomposum; in Zimbabwe, it overlaps with A. hebraeum, and in East Africa (from 
Sudan to Tanzania) it is present simultaneously with A. lepidum. [31][33] 
From its original source, A. variegatum was introduced in the Yemen, Arab republic and in different islands 
around Africa. It has thus been recorded in Capo Verde islands [31] and in Indian Ocean islands: Madagascar, La 
Réunion, Mauritius, the Seychelles and the four Comoros islands (Grand Comore, Anjouan, Moheli, Mayotte). 




Figure 4: Distribution of the major Amblyomma spp. vectors of Ehrlichia ruminantium in Africa. [3] 
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Pathogenesis of Heartwater  
Although heartwater pathogenesis is poorly understood despite being extensively studied, it is generally 
accepted that the determining lesion in the pathogenesis of heartwater is an increased vascular permeability of 
smaller blood vessels [12]. However, exactly how this increased permeability is caused is not yet clearly defined.  
Van Amstel et al. [28] reviewed the clinical pathological changes that occur during a heartwater infection. Most of 
these changes coincide with the onset of the febrile reaction. A progressive anaemia develops during the course 
of infection and it has been suggested that this anaemia is caused by a bone marrow depression [28]. Together 
with a drop in haematocrit, a neutropaenia, an eosinopaenia and a lymphocytosis are the most marked and 
consistent changes seen in the haemogram associated with heartwater [28]. 
 
Immunity to Heartwater 
Laboratory experiments as well as field observations have shown that cattle, sheep and goats are capable of 
developing a protective immunity against heartwater after surviving a virulent challenge (van Amstel, 1987). 
However, partial or total lack of cross protection between different isolates of E. ruminantium has been 
demonstrated (Du Plessis et al. 1994; Jongejan et al. 1991).  Interestingly, immunity to the Welgevonden 
isolate of E. ruminantium has been shown to confer protection to a number of other virulent southern African 
stocks such as the Ball 3, Mara 87/7, Blaaukrans and Gardel [10][13] and it is for this reason that the Welgevonden 
stock would be the most suitable as a vaccine candidate for South Africa.  
It is also known that young animals possess an innate resistance to the disease, irrespective of the immune 
status of the dam. In calves this lasts up to the age of four weeks and in lambs up to at least seven days [14].  
The mechanism by which the immune response develops is not entirely clear, but it has been suggested that 
cellular immunity, rather than humoral immunity, is the predominant response [25][26]. This also became evident 
in a study by Mahan et al. [17] where they demonstrated that the inactivated vaccine prepared in adjuvants that 
preferentially induce humoral immunity did not protect against heartwater challenge, but vaccines prepared 
with adjuvants which induce cellular immunity were more efficient in protecting sheep against lethal heartwater 
challenge. Serum antibodies are produced in response to infection but they do not appear to correlate with 
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Hearwater, in clinically affected animals, is characterised by sudden onset of high fever, which may be 
accompanied by nervous signs and may be followed more or less rapidly by death. The disease usually develops 
within 10 to 30 days after an infectious tick bite and the first symptom usually is a sudden rise in body 
temperature. 
Clinical signs in susceptible animals include fever, lack of appetite, incoordination, respiratory distress, nervous 
symptoms and death [23][32]. These signs are mostly related to an increased capillary permeability, which leads to 
the excess effusion of fluid into tissues and the body cavities [23]. The course of the disease can be quite variable, 
ranging from peracute to mild depending on the age, immune status, individual or breed susceptibility of the 
animal and virulence of the isolate [32]. 
The severity of clinical signs and mortality rate depend on the species, breed and age of the ruminant host, the 
route of infection (tick transmitted or needle-inoculated), the virulence of the E. ruminantium isolate and the 
size of the inoculum. Young animals immediately after birth, irrespective of breed and the dam’s immune status 
have been reported to possess innate resistance to heartwater [32]. The duration of this inverse-age resistance 
varies amongst species. It is reported to be 9 days in Merino lambs, 2 weeks in kids and 2 to 3 weeks in calves 
[9][32]. 
Subclinical infections:  Mild or latent infections, revealed by a marked pyrexia and followed within 2-3 d by 
complete recovery, are known. The incidence of this form is unknown owing to the inapparent symptoms [23], 
but should be substantial. This course is seen in some indigenous populations in endemic areas, very young 
animals, immune or partially immune animals and treated stock [32]. Recovered sheep, goats and cattle, as well 
as African buffalo, become long-term carriers [7]. 
Per-acute infections: This form of infection is characterized by sudden death some 36 h after clinical symptoms 
first appear. Symptoms are of a fulminating temperature in an animal with otherwise normal appearance and 
behaviour, followed by paroxysmal convulsions, respiratory distress and sudden collapse. Both goats and sheep 
are vulnerable, but peracute cases are more common in the former [3].  
Acute infections: This is the classical, most common form of infection in susceptible animals [23]. Pyrexia of 
several days duration, subsiding when death approaches, is followed by listlessness, rapid pulse and tachypnoea, 
and a disturbed expression in the eyes. Nervous symptoms ensue, such as a twitching of facial muscles and high 
stepping gait [32]. Sheep and goats show a progressive incoordination and stand in an attitude with head down, 
ears drooping, and thorax heaving. Hydrothorax (but seldom hydropericardium) may be established by 
percussion. Following this, the animal often collapses and lies on its side with its head thrown back, while 
showing strabismus, galloping movements of the legs, masticatory and licking movements of the mouth, and 
frothing from the nostrils. Feeding frequently continues until shortly before collapse. The temperature shows an 
abrupt drop to subnormal, prior to death. Clinical signs may last 3- 5 days and, in animals that go down, recovery 
is rare. Recovered sheep may shed part or all of the fleece.  
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Subacute infections: Symptoms here resemble those seen in acute cases, but are less pronounced [32]. Fever may 
persist for 10-15 d, and pregnant animals are prone to abort. Animals may collapse and die, with death often 
due to complications, such as pneumonia or sequelae resulting from atony of the fore stomachs, otherwise a 
gradual subsidence of symptoms followed by recovery may occur. 
 
Mortality rates vary between 5 % and 100 % [9][23]. Mortality rate in indigenous goats in an endemic area of 
Guadeloupe has been estimated at around 10 % [9].  
Pathology: Most lesions are restricted to acute and sub-acute forms of infection, and may vary according to the 
stock of Cowdria involved. 
Post-mortem pathology: Lesions among domestic ruminants are similar, with some exceptions. Effusion of body 
cavities, especially thoracic cavities, is commonly seen in fatal cases, amounting to 0,5 liter or more in sheep, but 
barely more than 20 ml in goats. Hydropericardium (from which the disease gets its name) is a regular finding, 
and is more pronounced in sheep and goats than in cattle. The lungs, mediastinum and associated lymph nodes 
are oedematous and a serous, frothy fluid oozes from cut surfaces of the lungs. In peracute cases, marked 
oedema of the lungs, and froth in the trachea and bronchi are striking enough to explain death by asphyxia [9]. 
Splenomegaly occurs in over 90% sheep and goats, but enlargement may not be marked. Other workers have 
not frequently observed splenomegaly in small ruminants [9]. The lymph nodes are swollen and the kidneys 
somewhat pale. The liver is congested, often showing fatty degeneration, but hepatic lesions are not striking [9]. 
Enteritis is seen less often in small stock than in cattle. Except for congestion of meningeal vessels or occasional 





A presumptive or tentative diagnosis of heartwater is based on the presence of Amblyomma vectors, nervous 
signs, and presence of transudates in the pericardium and thorax on post-mortem examination.  
In clinically ill animals, blood samples should be collected for PCR. PCR can sometimes detect organisms in the 
blood or bone marrow of carriers. For culture, blood is collected into an anticoagulant and diluted in culture 
medium; details are available in the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals [33]. 
Samples should be kept refrigerated and shipped with ice packs. Serum may be collected for serology. 
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The peracute form of heartwater can be confused with anthrax. The acute form may resemble rabies, tetanus, 
bacterial meningitis or encephalitis, babesiosis, anaplasmosis, cerebral trypanosomiasis, or theileriosis. It must 
also be differentiated from poisoning with strychnine, lead, ionophores and other myocardial toxins, 
organophosphates, arsenic, chlorinated hydrocarbons, or some poisonous plants (Cestrum laevigatum, Pavetta 
species, and Pachystigma species). Accumulations of fluid similar to heartwater are also sometimes seen in 
heavy helminth infestations [9][23] 
It is confirmed by the finding of characteristic colonies of the causal agent in capillary endothelial cells, 
particularly of brain smears [33], or by sub-inoculating blood of sick animals into susceptible ruminants. Brain 
smears are usually done at autopsy, but can be made from the living animal by needle biopsy [32]; however, this 
is impractical on a routine basis for a number of reasons. 
 
Pathology and post-mortem diagnosis 
Post-mortem examinations are usually only conducted for particularly valuable animals, so, even in an endemic 
area, relatively few are carried out. The classical post-mortem signs of heartwater are hydropericardium, 
hydrothorax (Figure 5) and oedema of the lungs and brain; however, some or all of these signs may be absent 
and a final diagnosis depends on the observation of E. ruminantium colonies in the cytoplasm of brain 
endothelial cells. The normal procedure is to examine brain smears after staining with Diff-Quik (a commercial 
Giemsa-type stain), but veterinarians faced with sick animals which may have heartwater normally treat them 
with tetracycline, which makes colonies of the organism more difficult to detect at any subsequent post-
mortem. [23][32] 
E. ruminantium occurs as clumps of reddish-purple to blue, coccoid to pleomorphic organisms inside capillary 
endothelial cells. These organisms are often found close to the nucleus, and may be in a ring or horseshow. E. 
ruminantium can also be detected in formalin-fixed brain sections using immunoperoxidase techniques. Only a 
few colonies may be found in animals with peracute disease. 
The colonies are still visible 2 days after death in a brain that has been stored at room temperature (20–25°C) 
and up to 34 days in a brain that has been stored in a refrigerator at 4°C. [33] 
In situation where colonies in brains smears are difficult to be detected, the preferred method is to stain 
formalin fixed tissue sections with an immunoperoxidase-labelled polyclonal antibody against E. ruminantium, 
followed by counterstaining with haematoxylin, which enables the infecting organisms to be easily identified 
within cells from selected tissues, organs and lesions. 
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There are only two types of practical test for diagnosing heartwater in live ruminants: serological tests and 
molecular genetic tests, and the latter can also be used to diagnose the disease in vector ticks. 
Current serological tests are based on the detection of antibodies to the immunodominant E. ruminantium outer 
membrane protein MAPI, and the most reliable of these tests uses a recombinant fragment of MAPI (MAPIB) in 
an indirect enzyme-linked immunosorbent assay (ELISA) format [33] 
Other serological tests available include indirect fluorescent antibody tests, ELISAs and Western blot. However, 
when the whole E. ruminantium is used as antigen, cross-reactions with Ehrlichia spp. occur in all of these tests. 





Figure 5: Hydropericardum and Hydrothorax in Heartwater [1] 
 
Molecular tests 
The first E. ruminantium-specific genetic target used for a diagnostic test was a plasmid clone, designated pCS20, 
from a genomic library of the virulent Crystal Springs isolate from Zimbabwe [3]. The target region consists of two 
overlapping genes. The tests that have been developed to detect this region all use a variation of PCR 
amplification, whether directly, in a nested format, in a quantitative real-time format, or in a loop-mediated 
isothermal amplification (LAMP) format. There are sequence polymorphisms, mostly single nucleotide 
polymorphisms, among the pCS20 regions of different E. ruminantium isolates, but there are also more 
divergent homologs in all known Ehrlichia spp. The pCS20 test can therefore give positive signals with DNA from 
organisms other than E. ruminantium, most notably with E. chaffeensis and E. canis; nevertheless, when the test 
is properly calibrated, these signals are an order of magnitude lower than those given by an equivalent 
concentration of E. ruminantium DNA. Extensive use of the pCS20 test over more than 20 years has shown that 
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it can specifically identify E. ruminantium in domestic animals, wild game and ticks. The quantitative real-time 
format for this test appears to be the most sensitive for examining field samples, while the LAMP format may be 
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While heartwater has been shown to be endemic in several African countries, there are very limited data on its 
incidence and prevalence due to several reasons, including the difficulties in diagnosing the disease, the lack of 
diagnostic capacity in most countries, ongoing use of acaricides and antibiotics in certain regions, the situation 
of endemic stability in many affected areas which tends to show low incidence of the disease while preventing 
the introduction of new naïve animals.  
Incidence data provided to the OIE or AU-IBAR are generally from the same countries, while the disease is 
known to occur in much more other countries. However, it can be noted that heartwater has consistently be 
among the top 11 diseases reported in terms of annual number of outbreaks.  
Another observation that could be made from the AU-IBAR report is the fact that countries with better 
organised veterinary services or countries with commercial farming systems, such as those in Southern Africa. 
There is also regular report of high number of outbreaks in Somalia, due essentially to the presence of several 




Incidence data by country 
Table 5: Number of heartwater outbreaks reported to the OIE between 2005-2015 (Numbers given only for 
the target countries) Source: OIE.  
http://www.oie.int/wahis_2/public/wahid.php/Diseaseinformation/statusdetail 
 
Country 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 
Asia 
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Bangladesh NA NA NA NA NA NA NA NA NA NA NA 
India NA NA NA NA NA NA NA NA NA NA NA 
Indonesia NA NA NA NA NA NA NA NA NA NA NA 
Myanmar 
(Burma) 
NA NA NA NA NA NA NA NA NA NA NA 
Nepal NA NA NA NA NA NA NA NA NA NA NA 
Vietnam NA NA NA NA NA NA NA NA NA NA NA 
West Africa 
Burkina Faso 2 1 0 0 0 0 0 0 0 1 0 
Ivory Coast 0 0 0 0 0 0 0 0 0 0 0 
Mali 0 0 ... ... 0 ... ... ... ... ... ... 
Senegal 1 0 0 0 1 0 0 0 0 1 0 
East Africa 
Ethiopia 0 0 0 0 0 1 + + 0 0 0 
Kenya ? ? ? ? ? ? ? ? ? 6 0 
Rwanda  ... ... 0 0 0 0 0 0 ... ... 
Tanzania 0 38 114 30 18 23 15 7 11 15 5 
Uganda ... ... ... ... ... ... ... ... ... ...  
Southern Africa 
Madagascar 28 4 12 + + 14 8 6 8 7 0 
Malawi ... +.. +.. ... +.. ... ... 0 +..   
Mozambique 5 4 12 5 4 5 7 1 3 5 0 
South Africa 250 181 122 231 188 153 145 105 94 55 0 
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Zambia … 36 36 89 147 94 0 57 106 97 0 
 
Legend  
0 Continuing previous outbreak (s) 
... No information available for this disease 
0 Disease absent 
? Disease suspected 
+? Infection/infestation 
+.. Disease present but without quantitative data 
+ Disease present with quantitative data but with an unknown number of outbreaks 
+() Disease limited to one or more zones 
+?() Infection/infestation limited to one or more zones 
?() Disease suspected but not confirmed and limited to one or more zones 
 
 
2- AU-IBAR:  The number of outbreaks reported to AU-IBAR is included in the Pan African Animal Resources Year 
Book. (http://www.au-ibar.org/pan-african-animal-resources-yearbook?showall=&limitstart=) and can be 
seen for the countries of interest in Table 6 below.   
Table 6: Number of heartwater outbreaks reported to the AU-IBAR from 2005 to 2015 (numbers given only 
for the target countries). Source: AU-IBAR Year Books. 
 
Country 2005* 2006* 2007* 2008 2009 2010 2011 2012 2013 2014 2015 
West Africa 
Burkina Faso          1  
Ivory Coast            
Mali            
Senegal     1       
East Africa 
Ethiopia      1      




60 45 17 2  
Rwanda            
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10 10 11 14  
Uganda     2       
Southern Africa 






19     
Malawi            
Mozambique  8 8 4 4 7 8  3 4  
South Africa  174 191 230 70 129  97 101 60  
Zambia   41 11 40 40 74 38 106 97  
 
*AU-IBAR didn’t start yet producing data for Heartwater 
**: There were no outbreaks reported, but cases were reported from outbreaks started during the previous 
year. 
NS+ Not specified  
 
 
Prevalence data by country 
Prevalence information of Heartwater (or its vector A. variegatum) in the different countries (Data from 2000-
2015) is very limited. 
 
Burkina Faso 




% positive Reference 








An average prevalence by 
PCR of ticks collected on 
cattle, sheep and goat of 
3.65 (80 animals)  
57.9% of ticks were A. 
variegatum 
Dr. Adakal PhD 
(2008) 
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Duguma 2012: http://idosi.org/gv/GV8(1)12/11.pdf  
Kifle 2014: http://www.idosi.org/gjms/gjms9(2)14/1.pdf  
 
Ivory Coast 




% positive Reference 




% positive Reference 
2014    A. variegatum is 
reported to account for 
40% of the tick 
population 
Kifle et al., 2014 
2012 Jimma town Small scale 
dairy 
farming 
54 Heartwater was the 
fourth most important 
problem identified, after 
mastitis, internal 
parasites and lumpy skin 
disease, mentioned by 
5.6% or participants. 
Duguma et al., 2012 
2012 Abernosa cattle 
ranch 
Ticks 120 Twenty of the ticks 
(16.6%) were positive 
for E. ruminantium 
Kifle et al., 2014 
1996 Abernosa cattle 
ranch 
  A. variegatum is 
reported to account for 
25% of the tick 
population. 
Kifle et al., 2014 
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 Amblyomma: overall 
prevalence 96%, 
Seroprevalence of E. 
ruminantium: 31% (95% 
CI: 26, 36%) 
Knopf et al, 2002 
Knopf 2002: http://www.ncbi.nlm.nih.gov/pubmed/11821134  
 
Kenya 




% positive Reference 






6 dead animals 
positive for 
Heartwater (7% of 
deaths) 
de Clare Bronsvoort, 
2013 and 
Thumbi, 2013 











Central Kenya Sheep 366 (that have 
died due to 
disease) 
Heartwater was 27% 
of all parasitic diseases 
that caused mortality 
Kagira et al, 2001 
1984-1998 Central Kenya Cattle 1,413 dead 
due to disease 
(177 due to 
parasites) 
TBD: 10.6% of all 
deaths. Of those, 
Heartwater was 10.2% 
Kanyari et al, 2000 
Thumbi 2013: http://www.ncbi.nlm.nih.gov/pubmed/24010500  
de Clare Bronsvoort 2013: http://www.ncbi.nlm.nih.gov/pubmed/24000820  
Wesonga 2006: http://www.ajol.info/index.php/bahpa/article/view/32727  
Kagira 2001: http://www.ncbi.nlm.nih.gov/pubmed/11811702    
Kanyari 2000:  http://www.ncbi.nlm.nih.gov/pubmed/11131115  
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• No recent information was available for Madagascar.  
Malawi 




% positive Reference 
1992 Near Lilongwe Zebu calves 90 Bimodal distribution showing a 
mixed population of Ab positive 
and negative animals 
77% exposed to A. variegatum 
Sumption et al, 2003 
Sumption 2003: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC193895/    
 
Mali 




% positive Reference 
2007 Animals coming 




 98% Mbengue et al, 2007 
Mbengue 2007: http://www.ncbi.nlm.nih.gov/pubmed/17645191  
 
Mozambique 









Goats 332 8.1% Bekker et al, 2001 






Asselbergs et al 1993 
Bekker 2001: http://www.ncbi.nlm.nih.gov/pubmed/11427440  
Asselberg 1993: http://www.ncbi.nlm.nih.gov/pubmed/8236490  
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• No recent information was available for Madagascar.  
 
Senegal 
• No recent information was available for Madagascar.  
 
South Africa 




% positive Reference 
2011 North West 
Province 
Ticks 42,566 A. hebraeum accounted 
for 17.3% of the ticks. 
Prevalent mainly in the 
north eastern region of 
the province 
Spickett et al, 2011 
2007-
2008 
Sweet and sour 




144 All negative Marufu et al, 2010 
Spickett 011: http://www.ojvr.org/index.php/ojvr/article/viewFile/305/347  
Marufu 2010: http://www.ncbi.nlm.nih.gov/pubmed/19733490  
 
Tanzania 




% positive Reference 








Swai et al, 2009a 
2008 Manyara Ranch, 
Monduli District 
Cattle 360 50.3 
 
Swai et al, 2008 
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2,600 ticks were 
collected from the 
cattle. A. variegatum 




Tanga region Cattle 549 56% deaths due to TBD. 
No mortality due to 
Heartwater 
Swai et al, 2009b 
Swai 2009a: http://www.ncbi.nlm.nih.gov/pubmed/19067218  
Swai 2008:  http://jsava.co.za/index.php/jsava/article/viewFile/247/225  
Swai 2009b: http://www.ncbi.nlm.nih.gov/pubmed/19091478  
 
Uganda 




% positive Reference 
2013 Moroto and 






Heartwater in Moroto 
was considered one of 
the most important 




perceptions but not 
testing data 
Byaruhanga et al 
Byaruhanga 2015: http://www.ncbi.nlm.nih.gov/pubmed/26527312  
 
Zambia 




% positive Reference 
2010- 
2011 
Mungwi Cattle 299 Only 1 sample positive, but A. 
variegatum were identified 
from 52.9% of the sampled 
Tembo, 2012 
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animals (sensitivity of the test 












Prevalence dry season / wet 
season: 
Eastern province: 5.45 – 18.96 
Central province: 37.75- 33.93 
Lusaka province: 45.31-29.27 
Overal: 17.11-23.78 
Simuunza, 2009 













A. variegatum constituted 
42.4% of the ticks 
 
 
Ahmadu et al, 2004 
Tembo 2012:  http://repository.up.ac.za/bitstream/handle/2263/26218/dissertation.pdf?sequence=1  
Simuunza 2009: http://theses.gla.ac.uk/1240/1/2009simuunzaphd.pdf  
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Economic and Social Impacts at Global 







Since heartwater is so common in the endemic areas of Africa, farmers are usually unwilling or unable to pay for 
definitive diagnoses, so it is difficult to quantify the economic impact of the disease [4]. An estimate in the 
literature applied to the Southern African Development Community, gives an indication of total animal 
production losses from the disease to be averaging US$48 million annually. 
The extensive study and report by Minjauw et al. [20] provide useful information on the impact of Heartwater on 
poor livestock keepers in Africa. See Table 7. 
Table 7: Estimated annual costs of tick-borne diseases in US$ [20] 
 
Country Cost 
Angola                  800 000    
Botswana                  400 000    
Malawi                  400 000    
Mozambique              3 000 000    
South Africa            31 600 000    
Swaziland              1 900 000    
Tanzania              2 900 000    
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Figure 7: Annual costs per head associated with Heartwater in cattle [20] 
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Except in the Republic of South Africa, E. ruminantium has a relatively small national impact, but since it is the 
only TBD to cause mortality in small ruminants, it can be of particular concern to commercial producers of these 
animals. The per head costs for E. ruminantium are generally higher for cattle than for small ruminants, 
suggesting that very little preventive action is taken for indigenous small ruminants. The reasons for this include 
the fact that turnover in small ruminant systems is relatively high, and, because reproduction rates are high 
compared to those of cattle, small ruminant flocks recover faster from mortality caused by disease outbreaks. 
Kivaria [16] established that the annual economic losses due to heartwater in Tanzania were totaling USD22, 43 
million, of which control through chemotherapy and acaricides counted for USD7 million, mortality USD 8.8 
million and production losses (milk and live weight more than USD6 million [16]    
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In free countries, it is important to prevent entry of infected animals or vectors. E. ruminantium cannot survive 
outside a living host for more than a few hours at room temperature. For this reason, heartwater is usually 
introduced in infected animals, including asymptomatic carriers, or in ticks. In heartwater-free countries, 
susceptible ruminants from endemic regions are tested before importation. All animals that may carry 
Amblyomma, including non-ruminant species, must be inspected for ticks before entry. In addition, ticks may be 
carried into a country on illegally imported animals or migrating birds. 




In endemic areas, animals with heartwater can be treated with antibiotics. Tetracycline is effective during the 
early, febrile stages of this disease, but animals often die before treatment can be administered. Antibiotic 
treatment alone is not always successful in later stages.  
Various formulations of the tetracyclines are almost invariably used for treatment of heartwater, administered 
at the rate of 8-10 mg/kg [28]. 
Treatment of small stock showing clinical signs has resulted in a 48% recovery rate (Du Plessis et at. 1994). 
Uleron, the first agent found to be effective in treating heartwater in sheep, is one of many sulphonamides used 
with good results. However, repeated doses may be necessary, and it is believed that tetracyclines are more 
effective [28]. 
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In endemic regions, heartwater can be prevented by tick control and vaccination. 
Tick control can be either intensive or strategic.  
Intensive tick control has largely fallen into disuse. The objective was to control all stages of ticks throughout 
the year and it was a system advocated for marginal areas where Amblyomma spp. were only found 
occasionally. The logistics and expense of such operations are formidable if they are applied over large areas, 
and acaricide resistance is a widespread problem. The main disadvantage, however, is that animals may lose all 
immunity to tick-borne diseases because of the lack of a natural challenge. Any breakdown of the intensive 
control regimen then results in heavy losses from heartwater and other tick borne diseases. 
Strategic tick control implies the control of tick numbers so that natural infection of livestock occurs and high 
levels of immunity are maintained. The aim is to achieve an epidemiologically stable situation with respect to 
heartwater by the regulation of the numbers of ticks present so as to prevent the debilitating effects of severe 
tick infestations. It is usually recommended that animals should be dipped only if they are carrying, on average, 
more than 10 adult Amblyomma ticks each. The animals should be monitored weekly in summer and autumn 
immediately after or during periods of good rains, and every two to three weeks in winter. It has been shown 
that this approach can lead to endemic (or enzootic) stability, even when the strategy is somewhat erratically 
applied. Economic studies have demonstrated that strategic tick control is both a more economical and a more 
practical option for limiting losses from heartwater and other tick-borne diseases. In fact, the counter-intuitive 
observation has been made that direct tick-borne disease losses increase with increasing use of acaricides. [3][8] 
Long-term immunity may be conferred to young stock by exposing them to infected ticks, rather than through 
vaccination. This occurs when the animals are first introduced into endemic stable areas, especially during times 
of tick activity [7] 
A point worth noting is that heartwater can be eradicated from a region by eliminating its vectors. Amblyomma 
ticks can be difficult to eradicate due to their high rate of reproduction, the wide variety of hosts they infest, and 
acaricide resistance. A regional program (The Caribbean Amblyomma Program) has been established to 
eradicate Amblyomma variegatum ticks from English and Dutch-speaking islands in the Caribbean. A 
complementary eradication program (POSEIDOM Vétérinaire Programme) has been conducted on French-
speaking islands. To date, these programs have succeeded in reducing the numbers of ticks on some islands and 
eradicating them from others, but complete eradication throughout the Caribbean remains elusive. [24] 
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Although vaccination methods described to date include infection and treatment, attenuated, DNA and 
inactivated vaccines, the only commercially available method, used in South Africa since decades, is the 
infection-and-treatment method which consists in inoculating intravenously virulent Ball 3 strain of ER (blood of 
an infected animal or tick homogenate) and subsequently treating with tetracycline. 
 
Disease situation and government policies by country 
Tables 8 and 9 below have been completed with the information received so far from the questionnaires sent to 
the DG and DVS.   
Table 8 covers the disease situation (if it is notifiable or not), the presence of official surveillance and/or control 
programs, and the treatment situation.  Table 9 table refers to vaccination. 
 
The definitions that were given to the respondents are: 
1Surveillance: is the systematic ongoing collection, collation and analysis of data and the timely dissemination 
of information to those who need to know so that action can be taken.  
2Control: a programme which is approved, and managed or supervised by the Veterinary Authority of a country 
for the purpose of controlling a vector, pathogen or disease by specific measures applied throughout that 
country, or within a zone or compartment of that country. 





















Burkina Faso      
Côte d'Ivoire (Ivory 
Coast)  
Yes - No - - 
Ethiopia      
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Kenya Yes Yes, passive No Yes Yes 
Madagascar      
Malawi No No Yes Yes Yes 
Mali - - - - - 
Tanzania  No Yes, passive Yes Yes Yes 
Uganda No No No N/A N/A 
Zambia Yes Yes, passive YEs Yes Yes 
 
No information from Mozambique, Rwanda, Senegal and South Africa 
-  Questionnaire received, but no information provided 
















Species vaccinated (cattle, 
sheep, goats, pigs, poultry) 
Burkina Faso     
Côte d'Ivoire (Ivory 
Coast) 
No - - - 
Ethiopia     
Kenya N/A N/A N/A N/A 
Madagascar     
Malawi No N/A N/A N/A 
Mali - - - - 
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Tanzania  No Not done Not done N/A 
Uganda No Never vaccinated N/A N/A 
Zambia No N/A N/A N/A 
 
No information from Mozambique, Rwanda, Senegal and South Africa 
-  Questionnaire received, but no information provided 
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The only commercially available procedure for heartwater immunisation is a more than 50-year old infection 
and treatment technique developed in South Africa. 
The only ‘vaccine’ currently commercially available is a cryopreserved preparation of blood from a sheep 
infected with virulent E. ruminantium organisms of the Ball-3 isolate [33]. The blood is injected intravenously in 
animals to be immunized, the rectal temperature is monitored daily, and antibiotic treatment is administered at 
the proper time. The infective blood must be preserved on dry ice or in liquid nitrogen and thawed shortly 
before inoculation, and the whole procedure must be supervised by trained staff. [21]. 
The Ball 3 stock was originally isolated in the Limpopo Province of South Africa and was chosen as the vaccine 
stock because it produces an early temperature rise several days before any other serious clinical signs appear. 
This makes it relatively easy to decide when to treat. [21] 
The vaccine is administered intravenously to sheep and goats in 5-ml amounts and the animals are monitored 
for onset of fever, after which they are treated. With Ball-3 vaccine stock, sheep may be safely treated on the 
2nd or 3rd day after onset of fever, thus insuring an adequate immune response [12]. 
Some immediate losses are to be expected owing to peracute reactions and, later, as a result of vaccine failures. 
Young lambs and kids (under 3 weeks old) are usually not monitored after immunization, but losses, especially in 
kids, can be expected. Where daily temperatures cannot feasibly be monitored, the antibiotic may be 
administered by the block method [12]. Here, small ruminants are treated, without reference to febrile reactions, 
on the 11th (sheep) or 12th (goats) day after vaccination. However, experience in South Africa has shown that 
Angora goats should not be treated by the block method but, like other valuable animals, should be monitored 
for rise in temperature, then treated [3]. 
The duration of immunity is uncertain, and because live organisms are involved the procedure cannot be used in 
non-endemic areas. The procedure is, however, successfully used to protect susceptible animals against the 
disease, especially when they are first introduced into endemic areas, or if they are particularly valuable.  
Limitations of the existing heartwater-infected blood vaccine are numerous. It is expensive to produce and 
store, cumbersome to transport and administer, highly strain-specific and potentially dangerous. In endemic 
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areas of South Africa, only an estimated 15% of farmers raising sheep and goats vaccinate their animals, and 
those that do suffer higher losses than those who do not [13]. An improved vaccine is clearly needed. 
 
Commercial vaccines manufactured in Africa  
 
 
Commercial vaccines imported into Africa 
 
The information summarised in Table 11, is based on a questionnaire send to the Director of Veterinary Services 
office and regulators of the countries of interest.  Note that some vaccines might have been imported under DVS 
dispensation, and they are not necessary licensed in the country.  
To the best of our knowledge, none of the target countries, in the exception of South Africa, Zambia and to a 
limited extend Mozambique, practices vaccination.  
None of the countries reported to have imported the vaccine, and this has been confirmed by the 
questionnaires.  
Table 10:  Heartwater vaccines manufactured in Africa 
 
Manufacturer Country Name & Strain Vaccine Type Countries distribution 
Onderstepoort Biological 
product 




South Africa, with 































- - - - - - - 
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Kenya - - - - - - - 
Malawi N/A N/A N/A N/A N/A N/A N/A 
Mali N/A N/A N/A N/A N/A N/A N/A 
Rwanda - - - - - - - 
Tanzania  - - - - - - - 
Uganda N/A N/A N/A N/A N/A N/A N/A 
Zambia N/A N/A N/A N/A N/A N/A N/A 
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Table 12 below provides the target minimum attributes of a heartwater vaccine, as well as those of an ideal 
vaccine 
Table 12:  Target Product Profile (TPP) heartwater – Proposal: 
 





Immunogen with protective 
antigens of E. ruminantium or A. 
centrale that protects against E. 
ruminantium infection 
Immunogen capable of providing full 
protection in cattle against E. 
ruminantium infection 
2 Indication for use For active immunization of cattle 
& water buffaloes 
For active immunization of cattle, water 
buffalos and all susceptible animals  
3 Recommended species 
 
Cattle, Water buffaloes All E. ruminantium susceptible livestock  
4 Recommended dose 
 
2 ml 1 ml 




vaccine) or ready to use solution 
(inactivated vaccine) 
Ready to use solution/suspension 
6 Route of administration 
 
intramuscular SC, Intramuscular or pour on 
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7 Regimen - primary vaccination Single dose Single lifetime dose 
8 Regimen - booster Single annual booster Lifelong immunity after primary 
vaccination 
9 Epidemiological relevance Protection against all 
geographically distinct strains of 
E. ruminantium  
Protection against RVF and prevention of 
virus transmission 
10 Recommended age at first 
vaccination 
• Animals over 3 months: one 
injection 
 
From 1-2 months of age  
11 Onset of immunity 
 
2-3 weeks following primary 
vaccination 
One week following primary vaccination 
12 Duration of immunity 
 
At least 1 year 
 
Lifelong immunity 
13 Expected efficacy To prevent disease & prevent 
mortality. 
To prevent infection and transmission. No 
disease & no mortality in vaccinated 
animals after virulent challenge. 
14 Expected safety In animals under 6 months of 
age, a transient pyrexia reaction 
can occur.  
A transient nodular reaction of 
varying importance, may appear 
at the injection site, it 
progressively disappears within 1 
to 2 months.  Only vaccinate 
pregnant animals on emergency. 
No post-vaccinal reactions at any age. Safe 
for pregnant animals.  
No carrier form in vaccinated animals 
15 Withdrawal period 
 
Nil Nil 
16 Special requirements for 
animals 
Do not vaccinate un-healthy 
animals 
Do not vaccinate un-healthy animals 
DIVA 
17 Special requirements for 
persons 
 None None 
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Overall conclusion for improved Heartwater control through vaccination 
South Africa continues to be the only country with a form of vaccination for a disease that is widespread 
throughout the whole Sub-Saharan Africa, and in some accounts considered to be the second most economically 
important TBD after ECF. Given the known limitation of treatment and vector control through the use of 
acaricides, a vaccine has been considered for many years as the most effective control strategy.  
From the present report it is clear that none of the vaccines developed to date has been satisfactory in ensuring 
commercial production. There are however a number of elements that could be considered for supporting the 
development of an effective vaccine:    
• There is a need to validate molecular tools for rapid strain matching, so that vaccine compatibility and 
suitability cold be ensured  
• Evaluate inactivated form of vaccines based on broad spectrum isolates or stock, such as Welgevonden, 
using knowledge accumulated by the different groups  
• Evaluate combination vaccination program, with priming with inactivated vaccine and boosting with live 
attenuated vaccine 
• Conduct a full development on the attenuated Welgevonden vaccine, essentially assess reversion to 
virulence and possibly lyophilisation 
• Development of robust challenge models, which should preferably include a tick challenge 
18 Package size 
 
50 doses Multiple pack size from 10 doses 
19 Price to end user 
 
Not more than $0.50/dose $0.20/dose at end user  
20 Storage condition and shelf-
life as packaged for sale 
12 months at 4-8° C   
 
 24 months 4-8° C and/or 48 hours at 30° 
C 
 
21 In-use stability 
 
1 hour 24 hours 
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• Reverse vaccinology for the identification and use of antigens that are targets of cellular immune responses 
through the work of some groups, such as University of Florida, could be an avenue for new vaccine 
development  
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ANNEX 1:  Additional data on disease presence 
and incidence 
 
Reports to OIE on heartwater: 
 
When different animal health statuses between domestic and wild animal population are provided, the box is 
split in two: the upper part for domestic animals, and the lower part for wild animals.  
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Heartwater in Eastern Africa:  Ethiopia, Kenya, Rwanda, Tanzania and Uganda 
 
Heartwater in Southern Africa: Madagascar, Malawi, Mozambique, South Africa and Zambia 
 
 
